COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Michel Choueiri, MD

Associate physician

Contact Information


Academic Profile

Dr. Choueiri completed his residency training at the University of Texas at Houston Medical Center. He joined the renowned MD Anderson Cancer Center as a post-doctoral fellow studying the bone metastasis of prostate cancer in Dr Sue-Hwa Lin's lab, then completed a fellowship in genitourinary medical oncology. Subsequently, he moved to San Diego where he pursued his training in Hematology Oncology. He has authored many book chapters and published peer reviewed articles. He is interested in entrepreneurship and serves as an advisor to medical companies in Southern California. His interests include traveling, calisthenics and martial arts. 

Representative Publications

Choueiri MB, Shen JP, Gross AM, Huang JK, Ideker T, Fanta P. ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer. PLoS One. 2015 Jun 17;10(6):e0126898. 

 Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat Genet. 2014 Sep;46(9):939-43.

Ye X, Lee YC, Choueiri M, Chu K, Huang CF, Tsai WW, Kobayashi R, Logothetis CJ, Yu-Lee LY, Lin SH. Aberrant expression of katanin p60 in prostate cancer bone metastasis. Prostate. 2012 Feb;72(3):291-300.

Choueiri M, Tannir N, Jonasch E. Adjuvant and neoadjuvant therapy in renal cell carcinoma. Curr Clin Pharmacol. 2011 Aug;6(3):144-50. 

Choueiri M, Jonasch E. Have molecularly targeted therapies improved overall survival in renal cell carcinoma? Curr Oncol Rep. 2011

Awards and Honors

Outstanding consultant of the year -2019- (Emergency Medicine dept)

I am proud to be a part of UC San Diego Health Hospital Medicine because it is a privilege and honor to be part of a team that strives to improve the lives of the San Diego residents on a daily basis, by fostering teamwork that not only includes cutting edge basic science research that is transferred to the clinic through the development of clinical trials, but also through the outstanding dedication of all healthcare providers to empower patients and put them at the center of all decisions pertaining to their health.